PTC-028
产品编号: DC7552
Featured
我们的合作伙伴:
中国地区超过5000个高品质化合物库存
应用领域
PTC-028 是一种口服有效的干细胞因子 BMI-1 的抑制剂，可用于治疗卵巢癌。PTC-028 选择性地抑制癌细胞，而正常细胞不受影响。PTC-028 对 BMI-1 的作用可诱导 caspase 介导的细胞凋亡 (apoptosis)。
| Cas No.: |
1782970-28-8 |
| 名称: |
6-(5,6-difluoro-2-methyl-1H-benzo[d]imidazol-1-yl)-N-(4-(trifluoromethyl)phenyl)pyrazin-2-amine |
| 别名: |
PTC028,PTC 028 |
| SMILES: |
C1=NC=C(N2C3C=C(F)C(F)=CC=3N=C2C)N=C1NC1=CC=C(C(F)(F)F)C=C1 |
| 分子式: |
C19H12F5N5 |
| 分子量: |
405.3 |
| 纯度: |
|
| 保存条件: |
2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO |
| Description: |
|
| In Vivo: |
|
| In Vitro: |
|
| References: |
PTC-028 (PTC028) is a novel potent, selective, orally bioavailable BMI-1 inhibitor with potent anti-MM activity against primary MM cells (IC50=10-100 nM); decreases BMI-1 levels by posttranslational modification, selectively inhibits cancer cells in clona |
| Kinase Assay: |
|
| Cell Assay: |
|
| Animal Administration: |
|
| References: |
|
MSDS
COA
| LOT NO. |
DOWNLOAD |
|
|
| 2018-0101 |
|
询盘
